Skip to main content

Table 2 Details of serum samples from ZIKV patients

From: Investigation of the immunogenicity of Zika glycan loop

IDAgeGenderDays after onset of symptomsZIKV H/PF NT90Mild symptoms*Guillain-Barré Syndrome
ARSZ1630846F51128,080YesNo
ARSZGB1601540F1415,150YesYes
ARSZGB1603148M3025,425YesYes
ARSZ1646744F3720,211YesNo